Search results for "s disease"

showing 10 items of 5637 documents

Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study

2011

medicine.medical_specialtybusiness.industryUrologyMEDLINEProstacyclinmedicine.diseaseSurgeryPhase i studyClinical trialTolerabilityInternal medicineMedicineIn patientPeyronie's diseasebusinessIloprostmedicine.drugBJU International
researchProduct

Enzyme replacement therapy for Fabry's disease – Authors' reply

2010

medicine.medical_specialtybusiness.industryUrologymedicineGeneral MedicineEnzyme replacement therapybusinessFabry's diseaseThe Lancet
researchProduct

Comparison of pegylated interferon α-2b plus psoralen PUVA versus standard interferon α-2a plus PUVA in patients with cutaneous T-cell lymphoma

2011

Objective  The aim of this study was to evaluate the safety and efficacy profile of pegylated interferon α-2b (PEG-IFN α-2b) in combination with photochemotherapy (PUVA) in the treatment of cutaneous T-cell lymphoma (CTCL) in comparison with standard IFN α plus PUVA. Design  Retrospective cohort study over a period of 7 years. Patients and interventions  A total of 17 consecutive CTCL patients (stage IA–IV) were retrospectively analysed for toxicity and response rates associated with PEG-IFN α-2b (1.5 μg/kg weekly) plus PUVA (n = 9) or standard IFN α-2a (9 MIU 3×/week) plus PUVA (n = 8). Main outcome measures  Differences of response rates (complete/partial remission), progression-free surv…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentCutaneous T-cell lymphomaDermatologymedicine.diseaseDermatologyGastroenterologyDiscontinuationchemistry.chemical_compoundInfectious DiseaseschemistryPegylated interferonInternal medicinePUVA therapyToxicitymedicinebusinessProspective cohort studyAdverse effectPsoralenmedicine.drugJournal of the European Academy of Dermatology and Venereology
researchProduct

Vaccinare per HPV: non solo le adolescenti e non solo profilassi. Review e position paper dell'Italian HPV Study Group (IHSG)

2020

HPV vaccination has been introduced in clinical practice in recent years and represents the most effective strategy of primary prevention of cervical carcinoma and of female genital preneoplastic conditions. One of the major issues of the subject is represented by vaccination coverage of the target population. Since its introduction, HPV vaccine efficacy has been progressively demonstrated also towards extragenital HPV-correlated conditions and in males too. Moreover, even subjects of older age groups or subjects who already had HPV infections have been demonstrated to received benefits from vaccination, due to improvements of their immunological response. Recently, vaccine efficacy has als…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentvirus diseasesObstetrics and GynecologyHpv vaccinationVaccine efficacyfemale genital diseases and pregnancy complicationsVaccinationInternal medicineVaccination coverageCervical carcinomamedicinePosition paperSex organbusinessAdjuvantMinerva Ginecologica
researchProduct

Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing

2020

Abstract Background Few data are reported in the literature about the outcome of patients with severe extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) infections treated with ceftolozane/tazobactam (C/T), in empiric or definitive therapy. Methods A multicenter retrospective study was performed in Italy (June 2016–June 2019). Successful clinical outcome was defined as complete resolution of clinical signs/symptoms related to ESBL-E infection and lack of microbiological evidence of infection. The primary end point was to identify predictors of clinical failure of C/T therapy. Results C/T treatment was documented in 153 patients: pneumonia was the most common diagnosis (n = 46…

medicine.medical_specialtyceftolozane/tazobactammedicine.medical_treatmentCRRTTazobactamEnterobacteralesEnterobacteraleInternal medicineCRRT; ESBL; Enterobacterales; ceftolozane/tazobactam; septic shockMajor ArticlemedicineClinical endpointRenal replacement therapybusiness.industrySeptic shockRetrospective cohort studyOdds ratiomedicine.diseaseCeftolozane/tazobactam; CRRT; Enterobacterales; ESBL; Septic shockAcademicSubjects/MED00290Infectious DiseasesOncologyESBLseptic shockCeftolozanebusinessEmpiric therapymedicine.drugOpen forum infectious diseases
researchProduct

Evaluation of the Burden of HPV-Related Hospitalizations as a Useful Tool to Increase Awareness: 2007–2017 Data from the Sicilian Hospital Discharge …

2020

In light of the implementation of human papillomavirus (HPV) prevention strategies, epidemiological studies in different geographical areas are required in order to assess the impact of HPV-related diseases. The purpose of the present study was to describe the burden of HPV-related hospitalizations in Sicily. A retrospective observational study estimated 43,531 hospitalizations attributable to HPV from 2007 to 2017. During the observed period, there was a decrease for all HPV-related conditions with a higher reduction, among neoplasms, for cervical cancer (annual percent change (APC) = &minus

medicine.medical_specialtycervical cancerImmunologyimpact evaluationcervical cancer screeninglcsh:MedicineCervical cancer screeningArticleburdenscreening effectiveness03 medical and health sciences0302 clinical medicineInternal medicineDrug DiscoveryCervical carcinomaEpidemiologyHospital dischargeScreening effectiveneMedicinePharmacology (medical)030212 general & internal medicineHPV vaccinePharmacologyCervical cancerHPV-related diseasevaccine effectivenessbusiness.industrylcsh:Rvirus diseasesRetrospective cohort studymedicine.diseaseVaccine introductionhospitalization rateAnnual Percent Changefemale genital diseases and pregnancy complicationsInfectious DiseasesItaly030220 oncology & carcinogenesisbusinessVaccines
researchProduct

Potential Involvement of Impaired Venous Outflow from the Brain in Neurodegeneration: Lessons Learned from the Research on Chronic Cerebrospinal Veno…

2019

About 10 years ago, the so-called chronic cerebrospinal venous insufficiency syndrome was discovered. This clinical entity, which is associated with extracranial venous abnormalities that impair venous outflow from the brain, was initially found exclusively in multiple sclerosis patients. Currently, we know that such venous lesions can also be revealed in other neurological pathologies, including Alzheimer’s and Parkinson’s diseases. Although direct causative role of chronic cerebrospinal venous insufficiency in these neurological diseases still remains elusive, in this paper, we suggest that perhaps an abnormal venous drainage of the brain affects functioning of the glymphatic system, whi…

medicine.medical_specialtychronic cerebrospinal venous insufficiencyDisease030204 cardiovascular system & hematologymultiple sclerosisjugular vein03 medical and health sciences0302 clinical medicineCerebrospinal fluidInternal medicineCranial cavitymedicineballoon angioplastyHumansPharmacologybusiness.industryMultiple sclerosisNeurodegenerationneurodegenerationBrainNeurodegenerative DiseasesGeneral Medicinemedicine.diseaseParkinson diseaseChronic cerebrospinal venous insufficiencymedicine.anatomical_structureVenous InsufficiencyRegional Blood FlowCerebrovascular CirculationChronic DiseaseCardiologyGlymphatic systemAlzheimer's diseaseAlzheimer diseaseJugular Veinsbusiness030217 neurology & neurosurgeryReviews on recent clinical trials
researchProduct

Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm

2020

The “novel” coronavirus disease 2019 (abbreviated “COVID-19”) is the third coronavirus outbreak emerging during the past two decades. This infectious disease, sustained by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has been recently declared a global pandemic by the World Health Organization. Despite the concerning epidemiological burden, many people, including some policymakers, are underestimating this pandemic and are remaining enigmatically inactive against a human pathology which, for a combination of reasons, can be reasonably defined as a perfect storm (i.e., the “wrong virus” at the “wrong time”). These many paradigmatic aspects include SARS-CoV-2 structure and pe…

medicine.medical_specialtycoronavirusOutbreakOutbreakReview ArticleGeneral Medicine030204 cardiovascular system & hematologymedicine.disease_causeepidemics03 medical and health sciences0302 clinical medicineInfectious disease (medical specialty)PandemicEpidemiologyCase fatality ratemedicinecoronavirus disease 2019 (COVID-19)030212 general & internal medicineOutbreak; coronavirus; coronavirus disease 2019 (COVID-19); epidemicsIntensive care medicineViral loadHuman PathologyCoronavirusAnnals of Translational Medicine
researchProduct

COVID-19 Deaths: Are We Sure It Is Pneumonia? Please, Autopsy, Autopsy, Autopsy!

2020

The current outbreak of COVID-19 severe respiratory disease, which started in Wuhan, China, is an ongoing challenge, and a major threat to public health that requires surveillance, prompt diagnosis, and research efforts to understand this emergent pathogen and to develop an effective response. Due to the scientific community’s efforts, there is an increasing body of published studies describing the virus’ biology, its transmission and diagnosis, its clinical features, its radiological findings, and the development of candidate therapeutics and vaccines. Despite the decline in postmortem examination rate, autopsy remains the gold standard to determine why and how death ha…

medicine.medical_specialtydiagnosisCOVID-19 ; autopsy ; infectious diseases ; diagnosisinfectious diseaselcsh:MedicineAutopsyDiseaseinfectious diseases03 medical and health sciences0302 clinical medicineautopsymedicineSampling (medicine)030216 legal & forensic medicineIntensive care medicinePostmortem Diagnosisbusiness.industryTransmission (medicine)Public healthGold standardlcsh:RCOVID-19General Medicinemedicine.diseasePneumoniaEditorial030220 oncology & carcinogenesisbusinessJournal of Clinical Medicine
researchProduct

Knowledge, Attitude and Practice of Hepatitis B Virus Infection among Dental Students and Interns in Saudi Arabia

2018

Background Hepatitis B virus (HBV) is a worldwide healthcare problem. Dental health care professionals are at a high risk of infection by HBV. The present study investigated the knowledge, attitude and practice of HBV infection among Saudi dental students and Interns in Saudi Arabia. Material and methods This was a questionnaire-based cross-sectional study. A self-administered questionnaire consisting of questions on students' knowledge, attitudes, and practices regarding HBV was used. Data of 420 participants were analyzed using SPSS (Statistical Package for Social Studies) version 22.0. Results The response rate was 84%. Overall, the participants showed fair level of knowledge about HBV, …

medicine.medical_specialtyeducationMEDLINENegative attitudemedicine.disease_cause03 medical and health sciences0302 clinical medicineHealth caremedicine030212 general & internal medicineGeneral DentistryHepatitis B virusResponse rate (survey)business.industryDental healthRisk of infectionResearchvirus diseases030206 dentistry:CIENCIAS MÉDICAS [UNESCO]digestive system diseasesCommunity and Preventive DentistryFace masksFamily medicineUNESCO::CIENCIAS MÉDICASbusinessJournal of Clinical and Experimental Dentistry
researchProduct